Financials & SEC Filings - Stoke Therapeutics

Filing date	Description	Form	View
November 7, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	0000950170-23-060224.pdf 0000950170-23-060224.rtf 0000950170-23-060224.xls EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT View HTML
November 9, 2023	Amendment to a previously filed SC TO-I	SC TO-I/A	0001193125-23-274539.pdf 0001193125-23-274539.rtf View HTML
November 16, 2023	UPLOAD	UPLOAD	0000000000-23-012558.pdf 0000000000-23-012558.rtf View HTML
November 17, 2023	Amendment to a previously filed SC TO-I	SC TO-I/A	0001193125-23-279830.pdf 0001193125-23-279830.rtf 0001193125-23-279830.xls View HTML
November 17, 2023	CORRESP	CORRESP	0001193125-23-279827.pdf 0001193125-23-279827.rtf 0001193125-23-279827.xls View HTML
December 1, 2023	Report of unscheduled material events or corporate event	8-K	0001193125-23-286862.pdf 0001193125-23-286862.rtf 0001193125-23-286862.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
December 5, 2023	Amendment to a previously filed SC TO-I	SC TO-I/A	0001193125-23-289154.pdf 0001193125-23-289154.rtf View HTML
December 5, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-057387.pdf 0001209191-23-057387.rtf 0001209191-23-057387.xls View HTML
December 5, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-057396.pdf 0001209191-23-057396.rtf 0001209191-23-057396.xls View HTML
December 5, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-057403.pdf 0001209191-23-057403.rtf 0001209191-23-057403.xls View HTML

Data provided by Kaleidoscope.